Aker BioMarine AS (AKBM.OL)
NOK 53.8
(1.51%)
NOK 53.8
(1.51%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 460.6 Million USD | 3.81% |
| 2022 | 443.7 Million USD | 14.62% |
| 2021 | 387.11 Million USD | 18.29% |
| 2020 | 327.26 Million USD | -39.13% |
| 2019 | 537.67 Million USD | 113.84% |
| 2018 | 251.43 Million USD | 0.0% |
| 2016 | 205.31 Million USD | 12.65% |
| 2015 | 182.26 Million USD | 1.31% |
| 2014 | 179.9 Million USD | 21.41% |
| 2013 | 148.17 Million USD | 4.72% |
| 2012 | 141.49 Million USD | 18.79% |
| 2011 | 119.11 Million NOK | 50.92% |
| 2010 | 78.92 Million NOK | -67.9% |
| 2009 | 245.9 Million NOK | 20.42% |
| 2008 | 204.21 Million NOK | -3.03% |
| 2007 | 210.58 Million NOK | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 454.6 Million USD | -0.92% |
| 2024 Q1 | 458.8 Million USD | -0.39% |
| 2023 Q2 | 467.4 Million USD | 1.43% |
| 2023 FY | 460.6 Million USD | 3.81% |
| 2023 Q4 | 460.6 Million USD | 0.5% |
| 2023 Q1 | 460.8 Million USD | 3.85% |
| 2023 Q3 | 458.3 Million USD | -1.95% |
| 2022 Q4 | 443.7 Million USD | 6.63% |
| 2022 FY | 443.7 Million USD | 14.62% |
| 2022 Q1 | 401.1 Million USD | 3.61% |
| 2022 Q2 | 406 Million USD | 1.22% |
| 2022 Q3 | 416.1 Million USD | 2.49% |
| 2021 Q3 | 385.91 Million USD | -4.11% |
| 2021 Q2 | 402.46 Million USD | 5.05% |
| 2021 Q4 | 387.11 Million USD | 0.31% |
| 2021 Q1 | 383.12 Million USD | 17.07% |
| 2021 FY | 387.11 Million USD | 18.29% |
| 2020 FY | 327.26 Million USD | -39.13% |
| 2020 Q1 | 529.36 Million USD | -1.55% |
| 2020 Q2 | 535.09 Million USD | 1.08% |
| 2020 Q3 | 324.81 Million USD | -39.3% |
| 2020 Q4 | 327.26 Million USD | 0.75% |
| 2019 FY | 537.67 Million USD | 113.84% |
| 2019 Q4 | 537.67 Million USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2018 FY | 251.43 Million USD | 0.0% |
| 2017 Q1 | - USD | -100.0% |
| 2016 FY | 205.31 Million USD | 12.65% |
| 2016 Q4 | 205.31 Million USD | 0.0% |
| 2016 Q1 | - USD | -100.0% |
| 2015 FY | 182.26 Million USD | 1.31% |
| 2015 Q4 | 182.26 Million USD | 0.0% |
| 2014 FY | 179.9 Million USD | 21.41% |
| 2014 Q4 | 179.9 Million USD | 0.0% |
| 2013 Q2 | 185 Million USD | -5.13% |
| 2013 Q3 | - USD | -100.0% |
| 2013 Q4 | 148.17 Million USD | 0.0% |
| 2013 FY | 148.17 Million USD | 4.72% |
| 2013 Q1 | 195 Million USD | 37.81% |
| 2012 Q3 | 130.05 Million NOK | 10.43% |
| 2012 FY | 141.49 Million USD | 18.79% |
| 2012 Q4 | 141.49 Million NOK | 8.8% |
| 2012 Q1 | 135.73 Million NOK | 13.95% |
| 2012 Q2 | 117.77 Million NOK | -13.23% |
| 2011 Q3 | 107.68 Million NOK | 16.19% |
| 2011 Q4 | 119.11 Million NOK | 10.62% |
| 2011 FY | 119.11 Million NOK | 50.92% |
| 2011 Q1 | 83.63 Million NOK | 5.96% |
| 2011 Q2 | 92.67 Million NOK | 10.81% |
| 2010 Q2 | 75.37 Million NOK | -69.55% |
| 2010 FY | 78.92 Million NOK | -67.9% |
| 2010 Q4 | 78.92 Million NOK | -5.72% |
| 2010 Q3 | 83.71 Million NOK | 11.06% |
| 2010 Q1 | 247.49 Million NOK | 0.65% |
| 2009 Q4 | 245.9 Million NOK | 0.0% |
| 2009 FY | 245.9 Million NOK | 20.42% |
| 2008 FY | 204.21 Million NOK | -3.03% |
| 2007 FY | 210.58 Million NOK | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Lerøy Seafood Group ASA | 21.49 Billion NOK | 97.858% |
| Orkla ASA | 39.84 Billion NOK | 98.844% |